These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Rossol M; Kraus S; Pierer M; Baerwald C; Wagner U Arthritis Rheum; 2012 Mar; 64(3):671-7. PubMed ID: 22006178 [TBL] [Abstract][Full Text] [Related]
3. Blocking of LFA-1 enhances expansion of Th17 cells induced by human CD14(+) CD16(++) nonclassical monocytes. Traunecker E; Gardner R; Fonseca JE; Polido-Pereira J; Seitz M; Villiger PM; Iezzi G; Padovan E Eur J Immunol; 2015 May; 45(5):1414-25. PubMed ID: 25678252 [TBL] [Abstract][Full Text] [Related]
4. CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses. Liu B; Dhanda A; Hirani S; Williams EL; Sen HN; Martinez Estrada F; Ling D; Thompson I; Casady M; Li Z; Si H; Tucker W; Wei L; Jawad S; Sura A; Dailey J; Hannes S; Chen P; Chien JL; Gordon S; Lee RW; Nussenblatt RB J Immunol; 2015 Jun; 194(11):5150-60. PubMed ID: 25911752 [TBL] [Abstract][Full Text] [Related]
5. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728 [TBL] [Abstract][Full Text] [Related]
6. The classical CD14⁺⁺ CD16⁻ monocytes, but not the patrolling CD14⁺ CD16⁺ monocytes, promote Th17 responses to Candida albicans. Smeekens SP; van de Veerdonk FL; Joosten LA; Jacobs L; Jansen T; Williams DL; van der Meer JW; Kullberg BJ; Netea MG Eur J Immunol; 2011 Oct; 41(10):2915-24. PubMed ID: 21695694 [TBL] [Abstract][Full Text] [Related]
7. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis. Zhao J; Zhao S; Zhou G; Liang L; Guo X; Mao P; Zhou X; Wang H; Nan Y; Xu D; Yu J Scand J Gastroenterol; 2011 Apr; 46(4):485-94. PubMed ID: 21275501 [TBL] [Abstract][Full Text] [Related]
8. Standardized flow cytometry assay for identification of human monocytic heterogeneity and LRP1 expression in monocyte subpopulations: decreased expression of this receptor in nonclassical monocytes. Ferrer DG; Jaldín-Fincati JR; Amigone JL; Capra RH; Collino CJ; Albertini RA; Chiabrando GA Cytometry A; 2014 Jul; 85(7):601-10. PubMed ID: 24639232 [TBL] [Abstract][Full Text] [Related]
10. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus. Burbano C; Vasquez G; Rojas M Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844 [TBL] [Abstract][Full Text] [Related]
11. CD16+ monocytes control T-cell subset development in immune thrombocytopenia. Zhong H; Bao W; Li X; Miller A; Seery C; Haq N; Bussel J; Yazdanbakhsh K Blood; 2012 Oct; 120(16):3326-35. PubMed ID: 22915651 [TBL] [Abstract][Full Text] [Related]
12. The CD14 Yin Q; Song D; Chen J; Ning G; Wang W; Wang S Clin Immunol; 2022 Dec; 245():109160. PubMed ID: 36270470 [TBL] [Abstract][Full Text] [Related]
13. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Liaskou E; Zimmermann HW; Li KK; Oo YH; Suresh S; Stamataki Z; Qureshi O; Lalor PF; Shaw J; Syn WK; Curbishley SM; Adams DH Hepatology; 2013 Jan; 57(1):385-98. PubMed ID: 22911542 [TBL] [Abstract][Full Text] [Related]
14. Xuemaitong granules attenuate carotid atherosclerosis by decreasing the expression of CD14+CD16+ monocytes, IL-6, TNF-α, and hsCRP. Zhang Q; Qian G; Ding Z Genet Mol Res; 2014 Sep; 13(3):7519-27. PubMed ID: 25222252 [TBL] [Abstract][Full Text] [Related]
15. Increased Toll-like receptor-2 expression on nonclassic CD16+ monocytes from patients with inflammatory stage of Eales' disease. Sen A; Chowdhury IH; Mukhopadhyay D; Paine SK; Mukherjee A; Mondal LK; Chatterjee M; Bhattacharya B Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6940-8. PubMed ID: 21791592 [TBL] [Abstract][Full Text] [Related]
16. CD14 Tsukamoto M; Seta N; Yoshimoto K; Suzuki K; Yamaoka K; Takeuchi T Arthritis Res Ther; 2017 Feb; 19(1):28. PubMed ID: 28183329 [TBL] [Abstract][Full Text] [Related]
17. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets. Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC Front Immunol; 2019; 10():1761. PubMed ID: 31402918 [TBL] [Abstract][Full Text] [Related]
18. The "Intermediate" CD14 Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581 [TBL] [Abstract][Full Text] [Related]
19. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis. Xiang Y; Liang B; Zhang X; Zheng F Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178 [No Abstract] [Full Text] [Related]
20. Activated Platelets Convert CD14 Lee SJ; Yoon BR; Kim HY; Yoo SJ; Kang SW; Lee WW Front Immunol; 2020; 11():611133. PubMed ID: 33488616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]